Oportun OPRT Reports Strong Q1 2026 Revenue NA EPS Beats Hindu Business Line Letters to the Editor May 15 2026 Reader Perspectives on Financial Currents Molson TAP Climbs 094 Resistance at 4326 in Focus 20260515 Teva Pharmaceutical TEVA Reports Q1 Beat Unveils Amylyx Deal Plans